Uganda Preparing for Covid-19 Vaccine Trials
The Uganda Virus Research Institute is partnering with Imperial College London to start the first Covid-19 vaccine trial in the country by December 2020. During the Global Vaccine Summit, hosted virtually by the UK government in June, the WHO welcomed a five-year, U.S.$1.6 billion commitment to Gavi, the Vaccine Alliance, to deliver lifesaving vaccines to the world's poorest countries. There are existing vaccine manufacturing capacities in African countries because some of these countries are involved in the development of vaccines, including yellow fever and Ebola, according Matshidiso Moeti, WHO Africa Regional Director. Uganda has 1,313 confirmed cases of Covid-19 and nine deaths.
As of January 21, 2022, confirmed cases of Covid-19 from 55 African countries reached 10,485,879 while over 204,551,125 vaccinations have been administered across the continent.
... Read more »
Africa has the capacity to mass-produce vaccines against COVID-19 if they become available next year but the region will need to be more involved in their search, writes Jackie ... Read more »
The South African Ox1Cov-19 Vaccine VIDA-trial developed by Wits University researchers is a first for Africa and one of 268 other candidate vaccines currently being researched and ... Read more »
The World Health Organisation has welcomed a five-year, U.S.$1.6 billion commitment to Gavi, the Vaccine Alliance, to deliver lifesaving vaccines to the world's poorest countries ... Read more »
President Yoweri Museveni has said that because some people had ignored with "indiscipline and Inconsideration" the measures imposed by the government, more stringent action had to ... Read more »